Viking Therapeutics, Inc. short interest in 2024
In 2024, Viking Therapeutics, Inc.'s disclosed short interest ran from 13.71% of shares outstanding on 12 Jan 2024 to 17.47% on 31 Dec 2024, a change of +3.76 percentage points. The year's high was 17.47% on 31 Dec 2024 and its low 9.48% on 28 Mar 2024, averaging 13.30% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.67 days on 15 Aug 2024. Full history: Viking Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 13.71% (12 Jan 2024)
- End of year
- 17.47% (31 Dec 2024)
- Change
- +3.76 pp
- High
- 17.47% (31 Dec 2024)
- Low
- 9.48% (28 Mar 2024)
- Average
- 13.30%
- Highest days to cover
- 6.67 (15 Aug 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 13.71% | 5.06 | |
| 31 Jan 2024 | 12.86% | 4.90 | |
| 15 Feb 2024 | 11.96% | 3.21 | 10-K filed, results (8-K) |
| 29 Feb 2024 | 12.22% | 1.00 | |
| 15 Mar 2024 | 11.09% | 1.18 | |
| 28 Mar 2024 | 9.48% | 1.65 | |
| 15 Apr 2024 | 10.11% | 4.09 | |
| 30 Apr 2024 | 10.98% | 4.61 | results (8-K), 10-Q filed |
| 15 May 2024 | 11.04% | 4.07 | |
| 31 May 2024 | 11.17% | 3.99 | |
| 14 Jun 2024 | 11.49% | 3.23 | |
| 28 Jun 2024 | 15.26% | 3.20 | |
| 15 Jul 2024 | 13.63% | 5.75 | |
| 31 Jul 2024 | 15.22% | 3.17 | 10-Q filed, results (8-K) |
| 15 Aug 2024 | 15.97% | 6.67 | |
| 30 Aug 2024 | 15.47% | 4.53 | |
| 13 Sep 2024 | 14.36% | 5.13 | |
| 30 Sep 2024 | 13.07% | 4.56 | |
| 15 Oct 2024 | 12.92% | 6.40 | |
| 31 Oct 2024 | 11.92% | 2.94 | 10-Q filed, results (8-K) |
| 15 Nov 2024 | 15.25% | 2.18 | |
| 29 Nov 2024 | 16.22% | 5.08 | |
| 13 Dec 2024 | 16.42% | 6.63 | |
| 31 Dec 2024 | 17.47% | 4.57 |
See also: Viking Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.